Prevention of Intra-Abdominal Adhesions Using the Combination of Mediclore® and a Statin
European Surgical Research · 2022 · 63 (3) · 123-131
DOI: 10.1159/000519708 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Surgical Research, online erschienen am 03.12.2021. Verfasst von Jesung Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, College of Medicine, Chung-Ang University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Purpose
This study investigated the antiadhesive effects of Mediclore®, rosuvastatin, and a combination of Mediclore and rosuvastatin in a rat adhesion model.
Methods
The adhesion models (a total of 58 adult male rats) were divided into 4 groups. The control group (group C) received no special materials except for a saline. The experimental groups were treated with 5 mL of Mediclore (group M), rosuvastatin (group R), or rosuvastatin and Mediclore (group RM), and these materials were intraperitoneally placed under the incision. At postoperative day 14, the rats underwent re-laparotomy and adhesiolysis. Three investigators blinded to group assignment scored the extent of adhesion formation, the numbers of remote adhesions, and the extent of acute/chronic inflammation, fibrosis, edema, and congestion on resected specimens via histologic examination.
Results
The macroscopic adhesion score in group RM (7.27 ± 3.51) was significantly lower than those in groups C (13.36 ± 2.24) and R (11.71 ± 1.98); group M (9.13 ± 4.09) had a significantly lower adhesion score than group C. The number of remote adhesions was significantly lower in groups R and RM than in group C. The acute inflammation score, chronic inflammation score, and fibrosis score in group RM; the acute inflammation score in group R; and the fibrosis score in group M were significantly lower than those in group C.
Conclusion
The intraperitoneal application of Mediclore and a combination of Mediclore and rosuvastatin effectively reduced postoperative adhesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
- Department of Anesthesiology and Pain Medicine, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
- Department of Pathology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
- Department of Surgery, Chung-Ang University Healthcare System Hyundae Hospital, Seoul, Republic of Korea.
Zitieren
APA
Park, J., Kang, H., Choi, Y. S., Suh, S. W., Hong, S. A., Choi, G. J., & Sim, W. J. (2022). Prevention of Intra-Abdominal Adhesions Using the Combination of Mediclore® and a Statin. European Surgical Research, 63(3), 123-131. https://doi.org/10.1159/000519708
Vancouver
Park J, Kang H, Choi YS, Suh SW, Hong SA, Choi GJ, et al. Prevention of Intra-Abdominal Adhesions Using the Combination of Mediclore® and a Statin. European Surgical Research. 2022;63(3):123-131. doi:10.1159/000519708
BibTeX
@article{Park2022,
author = {Park, Jesung and Kang, Hyun and Choi, Yoo Shin and Suh, Suk-Won and Hong, Soon Auck and Choi, Geun Joo and Sim, Woo Jung},
title = {Prevention of Intra-Abdominal Adhesions Using the Combination of Mediclore® and a Statin},
journal = {European Surgical Research},
year = {2022},
volume = {63},
number = {3},
pages = {123--131},
doi = {10.1159/000519708}
}
EUVIMED